Mercado de los medicamentos genéricos: Tendencias mundiales de la industria, cuota, tamaño, crecimiento, oportunidad y previsión 2024-2032

Mercado de los medicamentos genéricos: Tendencias mundiales de la industria, cuota, tamaño, crecimiento, oportunidad y previsión 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A15992

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Generic Drugs Industry
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Country
    5.5    Market Breakup by Therapy Area
    5.6    Market Breakup by Drug Delivery
    5.7    Market Breakup by Distribution Channel
    5.8    Market Forecast 
    5.9    SWOT Analysis
        5.9.1 Overview
        5.9.2 Strengths
        5.9.3 Weaknesses
        5.9.4 Opportunities
        5.9.5 Threats
    5.10    Value Chain Analysis
        5.10.1 Research and Development
        5.10.2 Manufacturing
        5.10.3 Marketing and Distribution
    5.11    Porter’s Five Forces Analysis
        5.11.1 Overview
        5.11.2 Bargaining Power of Buyers
        5.11.3 Bargaining Power of Suppliers
        5.11.4 Degree of Competition
        5.11.5 Threat of New Entrants
        5.11.6 Threat of Substitutes
    5.12    Regulations in the Generic Industry
    5.13    Key Market Drivers and Success Factors
6   Performance of Key Countries
    6.1    United States
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    China
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Brazil
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Germany
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    France
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    India
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    United Kingdom
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Japan
        6.8.1 Market Trends
        6.8.2 Market Forecast
    6.9    Canada
        6.9.1 Market Trends
        6.9.2 Market Forecast
    6.10    Italy
        6.10.1 Market Trends
        6.10.2 Market Forecast
    6.11    Others
        6.11.1 Market Trends
        6.11.2 Market Forecast
7   Market Breakup by Therapy Area
    7.1    Central Nervous System
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cardiovascular
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Dermatology
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Genitourinary/Hormonal
        7.4.1 Market Trends
        7.4.2 Market Forecast 
    7.5    Respiratory
        7.5.1 Market Trends
        7.5.2 Market Forecast 
    7.6    Rheumatology 
        7.6.1 Market Trends
        7.6.2 Market Forecast 
    7.7    Diabetes
        7.7.1 Market Trends
        7.7.2 Market Forecast
    7.8    Oncology
        7.8.1 Market Trends
        7.8.2 Market Forecast
    7.9    Others
        7.9.1 Market Trends
        7.9.2 Market Forecast
8   Market Breakup by Drug Delivery
    8.1    Oral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Injectables
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Dermal/Topical
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Inhalers
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Hospital Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
10  Competitive Landscape
    10.1    Market Structure
    10.2    Market Breakup by Key Players
    10.3    Key Player Profiles
        10.3.1 Teva Pharmaceuticals Industries Ltd.
        10.3.2 Mylan N.V.
        10.3.3 Novartis AG
        10.3.4 Pfizer Inc.
        10.3.5 Sun Pharmaceutical Industries Ltd.
        10.3.6 Fresenius SE & Co.
        10.3.7 Lupin Limited
        10.3.8 Endo Pharmaceuticals Inc.
        10.3.9 Aurobindo Pharma Limited
        10.3.10 Aspen Pharmacare Holdings Limited
11  Generic Drugs Manufacturing Process
    11.1    Product Overview
    11.2    Detailed Process Flow (Tablets)
    11.3    Detailed Process Flow (Injectable)
    11.4    Various Types of Unit Operations Involved
    11.5    Mass Balance and Raw Material Requirements
12  Project Details, Requirements and Costs Involved
    12.1    Land Requirements and Expenditures
    12.2    Construction Requirements and Expenditures
    12.3    Plant Machinery
    12.4    Machinery Pictures
    12.5    Raw Material Requirements and Expenditures
    12.6    Packaging Requirements and Expenditures
    12.7    Transportation Requirements and Expenditures
    12.8    Utility Requirements and Expenditures
    12.9    Manpower Requirements and Expenditures
    12.10    Other Capital Investments
13  Loans and Financial Assistance
14  Project Economics

    14.1    Capital Cost of the Project
    14.2    Techno-Economic Parameters
    14.3    Product Pricing and Margins Across Various Levels of the Supply Chain
    14.4    Taxation and Depreciation
    14.5    Income Projections
    14.6    Expenditure Projections
    14.7    Financial Analysis
    14.8    Profit Analysis

Mercado de los medicamentos genéricos: Tendencias mundiales de la industria, cuota, tamaño, crecimiento, oportunidad y previsión 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials